These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10263897)

  • 1. Hospital formulary system/drug product selection: similar or not?
    Fink JL
    Hosp Pharm; 1983 Nov; 18(11):590, 595-6. PubMed ID: 10263897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antisubstitution law changes and the hospital formulary system.
    Fink JL
    Am J Hosp Pharm; 1977 Jan; 34(1):90-3. PubMed ID: 831478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ASHP guidelines on formulary system management.
    Am J Hosp Pharm; 1992 Mar; 49(3):648-52. PubMed ID: 1598948
    [No Abstract]   [Full Text] [Related]  

  • 4. A survey of selective administration procedures in formulary maintenance.
    Quigley MA; Brown WM
    Hosp Pharm; 1981 Jul; 15(7):371-4, 378-80. PubMed ID: 10252001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic substitution and the hospital formulary system.
    Doering PL; McCormick WC; Klapp DL; Russell WL
    Am J Hosp Pharm; 1981 Dec; 38(12):1949-51. PubMed ID: 7325179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How to develop a proactive formulary system.
    Crane VS; Gonzalez ER; Hull BL
    Hosp Formul; 1994 Oct; 29(10):700-2, 704-8, 710. PubMed ID: 10137847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidelines on the operation of the pharmacy and therapeutics committee and formulary.
    Linkewich JA; Prevoznik SJ
    Hosp Pharm; 1979 Jan; 14(1):7-10, 13, 16-9 passim. PubMed ID: 10240149
    [No Abstract]   [Full Text] [Related]  

  • 8. Legal issues associated with formulary product-selection when there are two or more recognized drug therapies.
    Liang FZ; Greenberg RB; Hogan GF
    Am J Hosp Pharm; 1988 Nov; 45(11):2372-5. PubMed ID: 3228094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P & T Committee formulary requests: criteria for admission.
    Weintraub M; Guttmacher L
    Hosp Formul; 1984 Oct; 19(10):975-7, 980. PubMed ID: 10268315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hospitals vigilant for quality in pharmacy.
    Perry PA
    Hosp Mater Manage; 1989 Dec; 14(12):1-2. PubMed ID: 10296163
    [No Abstract]   [Full Text] [Related]  

  • 11. Formulary management: antibiotics and therapeutic interchange.
    Massoomi F
    Pharm Pract Manag Q; 1996 Oct; 16(3):11-8. PubMed ID: 10166231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purchasers review inventory during generics investigation.
    Hosp Mater Manage; 1989 Sep; 14(9):1, 7. PubMed ID: 10294707
    [No Abstract]   [Full Text] [Related]  

  • 13. Superior hospital formularies: a critical analysis.
    Rucker TD
    Hosp Pharm; 1982 Sep; 17(9):465-71, 474-5, 477-9 passim. PubMed ID: 10257551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Issues in formulary management: therapeutic interchange. Establishing guidelines: roundtable discussion, Part 1.
    Mahoney C; Cichon M; Cromer M; DeGiulio H; Renshaw B; Rodriguez FA; Wert D
    Hosp Formul; 1992 Oct; 27 Suppl 2():4-8. PubMed ID: 10122036
    [No Abstract]   [Full Text] [Related]  

  • 15. Issues in formulary management: therapeutic interchange. Communicating a policy: roundtable discussion, Part 2.
    Cichon M; Mahoney C; Renshaw B; Cromer M; Rodriguez FA; DeGiulio H; Wert D
    Hosp Formul; 1992 Oct; 27 Suppl 2():9-12. PubMed ID: 10122037
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapeutic substitution practices in short-term hospitals.
    Doering PL; Klapp DL; McCormick WC; Russell WL
    Am J Hosp Pharm; 1982 Jun; 39(6):1028-32. PubMed ID: 7102686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Point: the formulary system and the emperor's new clothes.
    Green JA
    Am J Hosp Pharm; 1986 Nov; 43(11):2830-4. PubMed ID: 3799622
    [No Abstract]   [Full Text] [Related]  

  • 18. Formulary decision making: identifying factors that influence P&T committee drug evaluations.
    Segal R; Pathak DS
    Hosp Formul; 1988 Feb; 23(2):174-8. PubMed ID: 10286022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Counterpoint: let's expand the formulary system and renew its vigor.
    Abramowitz PW; Fletcher CV
    Am J Hosp Pharm; 1986 Nov; 43(11):2834-8. PubMed ID: 3799623
    [No Abstract]   [Full Text] [Related]  

  • 20. Rational selection of H2-receptor antagonists for the hospital formulary. Roundtable discussion.
    Keeffe EB; Harper JM; LeMay A; Sherrin TP; Siepler JK
    Hosp Formul; 1991 Nov; 26 Suppl D():13-9. PubMed ID: 10136560
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.